Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nuvalent Inc Cl A (NUVL)

Nuvalent Inc Cl A (NUVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,762,240
  • Shares Outstanding, K 64,556
  • Annual Sales, $ 0 K
  • Annual Income, $ -126,220 K
  • 60-Month Beta 1.28
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.88
Trade NUVL with:

Options Overview Details

View History
  • Implied Volatility 36.10% ( -7.71%)
  • Historical Volatility 85.73%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 168.06% on 09/26/23
  • IV Low 36.10% on 09/18/24
  • Put/Call Vol Ratio 14.10
  • Today's Volume 468
  • Volume Avg (30-Day) 907
  • Put/Call OI Ratio 1.31
  • Today's Open Interest 19,854
  • Open Int (30-Day) 13,968

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.96
  • Number of Estimates 6
  • High Estimate -0.90
  • Low Estimate -1.14
  • Prior Year -0.59
  • Growth Rate Est. (year over year) -62.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.35 +47.39%
on 08/19/24
113.51 -7.36%
on 09/16/24
+33.60 (+46.95%)
since 08/16/24
3-Month
64.67 +62.61%
on 08/08/24
113.51 -7.36%
on 09/16/24
+27.06 (+34.65%)
since 06/18/24
52-Week
41.16 +155.49%
on 10/03/23
113.51 -7.36%
on 09/16/24
+60.68 (+136.42%)
since 09/18/23

Most Recent Stories

More News
Tech Stocks Close Lower on Weakness in Apple and Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) Monday closed up by +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.47%. Stocks...

$SPX : 5,624.05 (-0.19%)
SPY : 563.88 (+0.14%)
$DOWI : 41,555.86 (-0.12%)
DIA : 417.76 (+0.12%)
$IUXX : 19,368.61 (-0.33%)
QQQ : 473.58 (+0.02%)
ZNZ24 : 115-015 (-0.28%)
AAPL : 220.22 (+1.58%)
QRVO : 99.91 (-0.09%)
SWKS : 97.36 (+0.63%)
ARM : 139.23 (+1.75%)
MU : 87.68 (-1.18%)
Stocks Pressured by Apple and Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.19%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.92%. Stocks today are mixed,...

$SPX : 5,624.05 (-0.19%)
SPY : 563.88 (+0.14%)
$DOWI : 41,555.86 (-0.12%)
DIA : 417.76 (+0.12%)
$IUXX : 19,368.61 (-0.33%)
QQQ : 473.58 (+0.02%)
ZNZ24 : 115-015 (-0.28%)
AAPL : 220.22 (+1.58%)
QRVO : 99.91 (-0.09%)
SWKS : 97.36 (+0.63%)
ARM : 139.23 (+1.75%)
MU : 87.68 (-1.18%)
Stocks Pressured by Weakness in Apple and Chip Stocks

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up by +0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.84%. Stocks today are mixed,...

$SPX : 5,624.05 (-0.19%)
SPY : 563.88 (+0.14%)
$DOWI : 41,555.86 (-0.12%)
DIA : 417.76 (+0.12%)
$IUXX : 19,368.61 (-0.33%)
QQQ : 473.58 (+0.02%)
ZNZ24 : 115-015 (-0.28%)
AAPL : 220.22 (+1.58%)
MU : 87.68 (-1.18%)
ARM : 139.23 (+1.75%)
NVDA : 114.56 (-0.89%)
AVGO : 163.78 (+0.81%)
Why Nuvalent Stock Tanked on Tuesday

The dilution monster stalked the company following the announcement of a new capital-raising effort.

PIPR : 280.30 (+2.22%)
NUVL : 103.35 (-1.34%)
Nuvalent Announces Pricing of Public Offering of Common Stock

/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...

NUVL : 103.35 (-1.34%)
Nuvalent Announces Public Offering of Common Stock

/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...

NUVL : 103.35 (-1.34%)
Nuvalent Reports Preliminary Phase 1 Clinical Data from ALKOVE-1 Trial that Support Best-In-Class Potential of NVL-655 for Patients with ALK-Positive NSCLC

/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...

NUVL : 103.35 (-1.34%)
Why Nuvalent Stock Skyrocketed 35% This Week

Nuvalent announced favorable preliminary data in a clinical trial for its lung cancer drug. Here's what investors need to know.

NUVL : 103.35 (-1.34%)
Why Nuvalent Stock Was Soaring Wednesday

The company reported preliminary data on a non-small cell lung cancer therapy.

NUVL : 103.35 (-1.34%)
Preliminary Phase 1 Dose-Escalation Data from ALKOVE-1 Trial of NVL-655 Demonstrated Activity in Heavily Pre-Treated Patients with ALK-Positive NSCLC and an ALK-Selective, TRK-Sparing Safety Profile

/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...

NUVL : 103.35 (-1.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Nuvalent Inc. is a biopharmaceutical company. It focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. The company's program pipeline includes ROS1-positive and ALK-positive NSCLC. Nuvalent Inc. is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 114.45
2nd Resistance Point 112.22
1st Resistance Point 108.49
Last Price 103.35
1st Support Level 102.53
2nd Support Level 100.30
3rd Support Level 96.57

See More

52-Week High 113.51
Last Price 103.35
Fibonacci 61.8% 85.87
Fibonacci 50% 77.33
Fibonacci 38.2% 68.80
52-Week Low 41.16

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar